The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR.

[1]  M. Dank,et al.  [Monoclonal antibody therapy in breast cancer]. , 2013, Magyar onkologia.

[2]  M. Lotfy,et al.  MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis , 2011, Medical oncology.

[3]  Y. Kitagawa,et al.  Circulating tumor cells in gastrointestinal cancer , 2010, Journal of hepato-biliary-pancreatic sciences.

[4]  P. V. van Dam,et al.  Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer , 2009, British Journal of Cancer.

[5]  P. Schneider,et al.  Circulating Tumor Cells in Gastrointestinal Malignancies: Current Techniques and Clinical Implications , 2009, Journal of oncology.

[6]  S. Narod,et al.  Family history and the risk of gastric cancer , 2009, British Journal of Cancer.

[7]  H. Tanke,et al.  Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study , 2010, BMC Cancer.

[8]  J. García-Saenz,et al.  Circulating tumor cells in solid tumor in metastatic and localized stages. , 2009, Anticancer research.

[9]  P. Paterlini-Bréchot,et al.  Circulating tumor cells (CTC) detection: clinical impact and future directions. , 2007, Cancer letters.

[10]  A. Terano,et al.  Up‐regulation of TFF1 (pS2) expression by TNF‐α in gastric epithelial cells , 2007 .

[11]  M. Zembala,et al.  Circulating tumour cells and survival of patients with gastric cancer. , 2007, Anticancer research.

[12]  A. Terano,et al.  Up-regulation of TFF1 (pS2) expression by TNF-alpha in gastric epithelial cells. , 2007, Journal of gastroenterology and hepatology.

[13]  K. Alimoghaddam,et al.  Real-time PCR analysis of PML-RAR alpha in newly diagnosed acute promyelocytic leukaemia patients treated with arsenic trioxide as a front-line therapy. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  M. Hou,et al.  Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis. , 2006, Cancer letters.

[15]  M. Copin,et al.  Relationships between mucinous gastric carcinoma, MUC2 expression and survival. , 2006, World journal of gastroenterology.

[16]  Dong Xu,et al.  Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients , 2006, Journal of Zhejiang University SCIENCE B.

[17]  R. Rosenberg,et al.  Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma , 2006, The British journal of surgery.

[18]  Bjørn Naume,et al.  Circulating and disseminated tumor cells. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  T. Tajiri,et al.  Interleukin-8, Cyclo-oxygenase-2, and Trefoil Factor Family 1 Gene Expression and Their Association with Helicobacter pylori Infection in the Remnant Stomach , 2005, Surgery Today.

[20]  S. Braun,et al.  Circulating tumor cells in metastatic breast cancer--toward individualized treatment? , 2004, The New England journal of medicine.

[21]  D. Parkin.  International variation , 2004, Oncogene.

[22]  M. Ikeguchi,et al.  Detection of Circulating Cancer Cells After a Gastrectomy for Gastric Cancer , 2004, Surgery Today.

[23]  P. Neuhaus,et al.  Microscopic Tumor Cell Dissemination in Gastric Cancer , 2004, Surgery Today.

[24]  William E Gillanders,et al.  Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  S. Tsujitani,et al.  Detection of cancer cells in the peripheral blood of gastric cancer patients. , 2003, International journal of molecular medicine.

[26]  L. Frati,et al.  Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease. , 2003, Oncology reports.

[27]  T. Shuto,et al.  Transforming Growth Factor-β-Smad Signaling Pathway Cooperates with NF-κB to Mediate NontypeableHaemophilus influenzae-induced MUC2 Mucin Transcription* , 2002, The Journal of Biological Chemistry.

[28]  Tanja Fehm,et al.  Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  Masae Tatematsu,et al.  Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  G. Pelosi,et al.  The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients , 2002, British Journal of Cancer.

[31]  H. Kalthoff,et al.  Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. , 2001, Virchows Archiv : an international journal of pathology.

[32]  R. Ghossein,et al.  Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. , 2000, European journal of cancer.

[33]  E. Scarpi,et al.  Identification of occult micrometastases in patients with early gastric cancer using anti-cytokeratin monoclonal antibodies. , 2000, Oncology reports.

[34]  E. Osinaga,et al.  Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR. , 2000, European journal of cancer.

[35]  S. Braun,et al.  Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  T. Zhou,et al.  Detection of bone marrow micrometastasis. , 1999, Hybridoma.

[37]  H. Juhl,et al.  Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  S. Kim,et al.  Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer , 1998, Gastric Cancer.

[39]  S. Kim,et al.  Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer , 1998 .

[40]  A. Choy,et al.  Detection and enumeration of circulating tumour cells in colorectal cancer , 1993, The British journal of surgery.

[41]  Potter Jf,et al.  Cancer cells in the circulating blood. , 1959 .

[42]  Engell Hc.  [Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation]. , 1955 .